APPLICATIONS PUBLISHED 18 FEBRUARY 2004
Published: 1-Aug-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Topical compsns containing nonimmunosuppressive cyclosporin-derivatives for treating hair loss
LG Household & Health Care 1389086*
Topical product with visual indicator
Gillette 1387087*
Method and compsn for solubilising a biologically active compound with low water solubility
Phares Pharmaceutical Research 1389089*
Diagnostic imaging compsns, their methods of synthesis and use
Board of Regents, The University of Texas System 1389090*
Granular preparations of gaboxadol
H Lundbeck 1389091*
Abuse-resistant opioid dosage form
Endo Pharmaceuticals 1389092*
Pharmaceutical formulation
SmithKline Beecham 1389093*
Delivery of sedative-hypnotics through an inhalation route
Alexza Molecular Delivery 1389094*
Delivery of antidepressants through an inhalation route
Alexza Molecular Delivery 1389095*
Delivery of opioids through an inhalation route
Alexza Molecular Delivery 1389096*
Delivery of compounds for the treatment of Parkinson's through an inhalation route
Alexza Molecular Delivery 1389097*
Delivery of antipsychotics through an inhalation route
Alexza Molecular Delivery 1389098*
Delivery of beta-blockers through an inhalation route
Alexza Molecular Delivery 1389099*
Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
Cephalon 1389100*
Toluene sulphonamide-containing anti-tumour compsn and method of use thereof
PTS International 1389101*
Use of rare earth compounds for the prevention of kidney stone disease
Anormed 1389102*
Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
The University of Virginia Patent Foundation 1389103*
3-aminoalkyl-2-aryl-indole derivatives and their use as GNRH antagonists
AstraZeneca 1389104*
Method of treatment
Merck 1389105*
Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications
Universidade Federal de Minas Gerais-Ufmg 1389106*
Bisarylimidazolyl fatty acid amine hydrolase inhibitors
Bristol-Myers Squibb 1389107*
Methods for selective immunomodulation using pimecrolimus
Novartis 1389108*
Gastric acid secretion inhibiting compsn
Orexo 1389109*
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
Avanir Pharmaceuticals 1389110*
Compsn for inhibiting HIV activity extracted from Paecilomyces sp. (Tochu-kaso) J300
Republic of Korea 1389111*
Use of radical scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders
Boehringer Ingelheim Pharma 1389112*
Use of N-phenyl-2-pyrimidineamine derivatives against mast cell-based diseases like allergic disorders
Novartis; The Government of the United States of America, as represented by the Department of Veterans Affairs; Oregon Health and Science University; Koike, Kenichi; Komiyama, Atsushi 1389113*
Antihypertensive agent and cholesterol absorption inhibitor combination therapy
Merck 1389114*
As-needed administration of tricyclic and other non-SRI antidepressant drugs to treat premature ejaculation
Vivus 1389115*
Cathartic compsn
Sucampo 1389116*
Means and method for hormonal contraception
Pantarhei Bioscience 1389117*
Single daily-dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle
Flamel Technologies 1389118*
A pharmaceutical compsn comprising lyosophosphatidic acid
Biosynergen 1389119*
Identifying parasitic fungi of the organism, and treatment thereof
Antonov, Roumen 1389120*
Method and compsns for treating mammalian nerve tissue injuries
Purdue Research Foundation; The University of Chicago 1389121*
Prevention of epithelial cancer
Colotech 1389122*
A non-lethal method for extracting crude hemocyanin from gastropod molluscs
Stellar Biotech 1389123*
Palliative effects of morinda citrifolia oil and juice
Morinda 1389124*
Cross-linked gelatin compsn comprising a wetting agent
Sub-Q 1389125*
Retrocyclins: antiviral and antimicrobial peptides
The Regents of the University of California 1389126*
Compsns and methods for re-establishing gene transcription through inhibition of DNA methylation and histone deacetylase
SuperGen 1389127*
Method for inhibiting atherosclerotic plaque formation
Ludwig Institute for Cancer Research 1389128*
Methods of treating respiratory conditions
Monash University 1389129*
Use of orteopontin for the treatment and/or prevention of neurologic diseases
Applied Research Systems 1389130*
Combinations of a 5HT1 receptor agonist with an analgesic, and an anti-emetic and/or gastroprokinetic agent
Glaxo Group 1389131*
PEG-conjugates of HGT-NK4
Brandt, Michael 1389132*
Methods for inactivating viruses
Akzo Nobel 1389133*
Inhibitors of BACE
Vertex Pharmaceuticals 1389194*
Process for manufacturing an oxirane
Solvay 1389195*
Three-step conversion of protected taxane ester to paclitaxel
Napro Biotherapeutics 1389196*
Two-step conversion of protected taxane ester to paclitaxel
Napro Biotherapeutics 1389197*
Process for the preparation of prostaglandins and analogues thereof
Resolution Chemicals; Cascade Biochem 1389198*
Chiral compounds
Merck Patent 1389199*
Substituted N-arylsulphonyl-proline substitutes as potent cell adhesion inhibitors
Merck 1389200*
N-oxide anthranylamide derivatives and their use as medicaments
Schering 1389201*
2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
Bayer 1389202*
Analogues of thalidomide as potential angiogenesis inhibitors
The Government of the United States of America, as represented by The Secretary, Department of Health and Human Services 1389203*
Novel sulphonamide derivatives, intermediates thereof, its preparation methods, and pharmaceutical compsn comprising the same
Kolon 1389204*
Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
Ortho-McNeill Pharmaceutical Research 1389205*
Inhibitors of C-Jun N-terminal kinases (JNK) and other protein kinases
Vertex Pharmaceuticals 1389206*
Polymorphic and other crystalline forms of CIS-FTC
Triangle Pharmaceuticals 1389207*
Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor antagonists)
Pharmacia & Upjohn 1389208*
Folate mimetics and folate-receptor binding conjugates thereof
Purdue Research Foundation 1389209*
Tricyclic dihydro-quinoline derivatives, method for preparing same, and pharmaceutical compsns containing same
Les Laboratoires Servier 1389210*
3,7-diazybicyclo 3.3.1] formulations as antiarrhythmic compounds
AstraZeneca 1389211*
3,7-diazybicyclo 3.3.1] formulations as antiarrhythmic compounds
AstraZeneca 1389212*
3,7-diazybicyclo 3.3.1] formulations as antiarrhythmic compounds
AstraZeneca 1389213*
Process for the preparation of trialkylsilylated carboxylate monomers and their use in anti-fouling coatings
Sigma Coatings 1389214*
3-aryl substituted cyclopentadienyl metal complexes and polymerisation processes
Dow Global Technologies 1389215*
Antimicrobial polypeptide
Novozymes 1389217*
Cleavage and polyadenylation complex of precursor MRNA
Cellzome 1389218*
